AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 433.33 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $1.174 million which missed the analyst consensus estimate of $1.520 million by 22.76 percent. This is a 96.01 percent decrease over sales of $29.442 million the same period last year.